Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
57,779,618
-
Shares change
-
+1,950,415
-
Total reported value, excl. options
-
$3,648,879,764
-
Value change
-
+$120,117,247
-
Put/Call ratio
-
94%
-
Number of buys
-
99
-
Number of sells
-
-99
-
Price
-
$63.17
Significant Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q2 2014
247 filings reported holding ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2014.
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57,779,618 shares
of 131,516,365 outstanding shares and own 44% of the company stock.
Largest 10 shareholders include FMR LLC (11,333,008 shares), WELLINGTON MANAGEMENT CO LLP (9,132,117 shares), VANGUARD GROUP INC (3,276,926 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,252,033 shares), FRANKLIN RESOURCES INC (2,539,201 shares), GILDER GAGNON HOWE & CO LLC (1,995,870 shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (1,704,191 shares), BlackRock Institutional Trust Company, N.A. (1,557,699 shares), BlackRock Fund Advisors (1,407,823 shares), and BAILLIE GIFFORD & CO (1,190,930 shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.